Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-02-20, Stock:NVO, The news for the past five days is as follows:
2018-02-12: NEWS1: Health Care Sector Update for 02/12/2018: AXON,UTHR,NVO,FOLD,AVEO.NEWS2: Health Care Sector Update for 02/12/2018: AXON,UTHR,NVO,FOLD,AVEO.NEWS3: Noteworthy ETF Outflows: VEU, TD, SAP, NVO.NEWS4: Noteworthy ETF Outflows: VEU, TD, SAP, NVO.NEWS5: Blog Exposure - Novo Nordisk’s Ozempic is Approved in the EU for the Treatment of Type 2 Diabetes.NEWS6: GlaxoSmithKline plc -- Moody's: M&A greatest downside risk to European pharma companies' credit quality in 2018.NEWS7: Better Buy: Pfizer Inc. (PFE) vs. Eli Lilly (LLY).NEWS8: Better Buy: Pfizer Inc. (PFE) vs. Eli Lilly (LLY).
2018-02-13: NEWS1: Reviewing David’s '5 Stocks to Buy Into the Teeth of the Bear,’ and Picking 5 More.NEWS2: Reviewing David’s '5 Stocks to Buy Into the Teeth of the Bear,’ and Picking 5 More.
2018-02-14: NEWS1: FDA approves insulin dose calculator that&apos;s connected to a smartphone app.NEWS2: FDA approves insulin dose calculator that's connected to a smartphone app.
2018-02-15: NEWS1: 5 More Stocks to Buy to Feed the Bear.NEWS2: 5 More Stocks to Buy to Feed the Bear.NEWS3: 5 More Stocks to Buy to Feed the Bear.
2018-02-16: NEWS1: Top Research Reports for Novo Nordisk, TJX Companies & Cigna.NEWS2: Top Research Reports for Novo Nordisk, TJX Companies & Cigna.NEWS3: Top Research Reports for Novo Nordisk, TJX Companies & Cigna.NEWS4: Why 2018 Could Be An 'Explosive' Year For Biotech Mergers.NEWS5: Why 2018 Could Be An 'Explosive' Year For Biotech Mergers.NEWS6: Stocks To Watch: Bristol-Myers Squibb Sees RS Rating Jump To 83.NEWS7: Stocks To Watch: Bristol-Myers Squibb Sees RS Rating Jump To 83.

Answer: Decrease